PCSK9 and coronary artery disorder: Meanwhile, this study also pointed out that, lifetime exposure to reduced LDL-C levels mediated by genetic variants was related to a much greater reduction in the risk of CHD per unit decrease in LDL-C level than short-term PCSK9-mAbs therapy.